Patents by Inventor Clyde R. Goodheart

Clyde R. Goodheart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dry wound dressing and drug delivery system
    Patent number: 8377468
    Abstract: Dry dressings incorporate drug-delivery systems for anti-infective agents, growth factors, fibronectin or other substances to enhance tissue healing. A pharmaceutical composition includes hyaluronate polyvinylpyrrolidone (PVP), maltodextrin, and hydroxyethylcellulose and glycerin in the form of a membranous, wafer-like material after being freeze-dried.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: February 19, 2013
    Assignee: Rexaderm, Inc.
    Inventor: Clyde R. Goodheart
  • DRY WOUND DRESSING AND DRUG DELIVERY SYSTEM
    Publication number: 20090325861
    Abstract: Dry dressings incorporate drug-delivery systems for anti-infective agents, growth factors, fibronectin or other substances to enhance tissue healing. A pharmaceutical composition includes hyaluronate polyvinylpyrrolidone (PVP), maltodextrin, and hydroxyethylcellulose and glycerin in the form of a membranous, wafer-like material after being freeze-dried.
    Type: Application
    Filed: August 28, 2007
    Publication date: December 31, 2009
    Applicant: REXADERM ,INC.
    Inventor: Clyde R. Goodheart
  • Method of producing non-recombinant BMP-2 and use thereof
    Publication number: 20040023322
    Abstract: The invention features a method of producing non-recombinant BMP-2 by culturing mammalian cells that secrete BMP-2 and isolating the BMP-2 from the culture medium. The invention also features compositions containing purified BMP-2 and a method of using purified BMP-2 to promote bone formation.
    Type: Application
    Filed: August 1, 2002
    Publication date: February 5, 2004
    Inventor: Clyde R. Goodheart
  • Method for preparing cellular fibronectin
    Patent number: 5750378
    Abstract: A method for producing cellular fibronectin, said method comprising incubating fibronectin-producing cells in a fibronectin production medium comprising: (a) 1.0-3.5 g/L bicarbonate salt; (b) 1.0-5.0 g/L glucose; (c) 10-30 .mu.g/L dexamethasone; (d) 1-10 g/L hydrolyzed protein; and (e) 5-15 .mu.g/L insulin.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: May 12, 1998
    Assignee: Fibrogenex, Inc.
    Inventors: Clyde R. Goodheart, Ralph H. Silverman
  • Method for treating cancer resections
    Patent number: 5354269
    Abstract: A method for preparing fibronectin and further a process for treating cancer resections which prevents or reduces local recurrences of cancer in procedures in which cancerous tissues are resected comprising the steps of: mixing a pharmaceutical fibronectin with a suspending medium to provide a fibronectin composition; applying the fibronectin composition to a surgically exposed tissue from the cancer resection; and closing the surgically exposed tissue using conventional suturing techniques.
    Type: Grant
    Filed: December 20, 1991
    Date of Patent: October 11, 1994
    Assignee: Fibrogenex, Inc.
    Inventors: Clyde R. Goodheart, Ralph H. Silverman, M. Satya Murthy, Edward F. Scanlon